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Abstract
To further advance assessment of patient-reported outcomes, the European Organisation of
Research and Treatment of Cancer (EORTC) Quality of Life Group has developed com-
puterized adaptive test (CAT) versions of all EORTC Quality of Life Core Questionnaire
(QLQ-C30) scales/items. The aim of this studywas to develop and evaluate an item bank for
CAT measurement of insomnia (CAT-SL). In line with the EORTC guidelines, the devel-
opmental process comprised four phases: (I) defining the concept insomnia and literature
search, (II) selection and formulation of new items, (III) pre-testing and (IV) field-testing,
including psychometric analyses of the final item bank. In phase I, the literature search
identified 155 items that were compatible with our conceptualisation of insomnia, including
both quantity and quality of sleep. In phase II, following a multistep-approach, this number
was reduced to 15 candidate items. Pre-testing of these items in cancer patients (phase III)
resulted in an item list of 14 items, which were field-tested among 1094 patients in phase IV.
Psychometric evaluations showed that eight items could be retained in a unidimensional
model. The final item bank yielded greater measurement precision than the original QLQ-
C30 insomnia item. It was estimated that administering two ormore items from the insomnia
item bank with CAT results in a saving in sample size between approximately 15–25%. The
8-item EORTCCAT-SL item bank facilitates precise and efficient measurement of insomnia
as part of the EORTC CAT system of health-related quality life assessment in both clinical
research and practice.
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Introduction
Prevalence rates of insomnia as high as 60% have been reported in patients with cancer
(Savard et al. 2009), which is markedly higher than the <15% reported in the general
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population (Itani et al. 2016; Pallesen et al. 2014). Insomnia, or sleeplessness, has been
defined as a subjective feeling of poor or unsatisfactory sleep that may involve insufficient
sleep, difficulty falling asleep, difficultymaintaining sleep, early final wakening, and/or poor
quality or non-restorative sleep (O’Donnell 2004; Sateia and Lang 2008; Savard and Morin
2001). Factors contributing to insomnia include predisposing factors such as age and gender,
precipitating factors like medical treatment, and perpetuating factors such as poor sleeping
behaviour (Harris et al. 2014; Induru and Walsh 2014). Not only patients undergoing anti-
tumour treatment report high levels of insomnia (Savard et al. 2009; Costa et al. 2014;
Robertson et al. 2016); cancer survivors and advanced cancer patients report higher levels of
insomnia when compared to the general population (Arndt et al. 2017; Lowery-Allison et al.
2017; Mercadante et al. 2017).
Insomnia is typically measured with patient-reported outcome measures, for which
several instruments are available (Chen et al. 2018). Moreover, insomnia is often
included in measures of health-related quality life (HRQoL). One frequently used tool
to assess HRQoL in cancer patients is the European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (Aaronson
et al. 1993). This multidimensional instrument consists of 30 items comprising five
functional scales, three symptom scales, and six single item symptoms, including an
item on insomnia.
Static measures such as the QLQ-C30 require that all patients respond to all
questions, regardless of their relevance for any individual patient. Static instruments,
with a fixed number of items per domain of interest, may also yield suboptimal
measurement precision. The use of computerized adaptive testing (CAT) can overcome
these issues (Bjorner et al. 2007; Cella et al. 2007; van der Linden and Glas 2010). CAT
is a method of selecting the most relevant item set for an individual patient. A computer
algorithm selects a new item based on the patient’s response to the previous items. As a
result, fewer items are typically needed to obtain the desired level of measurement
precision. Importantly, results across patients or studies are still comparable, even if
patients do not answer the same subset of items. This is possible as CAT is based on
item response theory (IRT) methods (Hambleton et al. 1991).
The EORTC Quality of Life Group (QLG) has an on-going, large scale international
project to develop CAT versions of all EORTC QLQ-C30 scales/items (Dirven et al.
2017; Gamper et al. 2014, 2016; Giesinger et al. 2011; Petersen et al. 2011, 2013a, b,
2016a, 2018a; Thamsborg et al. 2015), and for several scales higher measurement
precision and reduced response burden has been achieved (Dirven et al. 2017; Gamper
et al. 2016; Petersen et al. 2011, 2013b, 2016a, b). Whether this holds true for other
scales remains to be determined. The EORTC CAT development process consists of
four phases: (I) conceptualisation and literature search, (II) selection and formulation of
new items, (III) pre-testing and (IV) larger scale field-testing, including psychometric
analyses of the final item bank. Here we report the results of phases I-IV of the
development and evaluation of an item bank for insomnia (EORTC CAT-SL).
Methods
The approach for the development of items banks for the EORTC CAT follows the
EORTC guidelines (Petersen et al. 2010, 2018; Johnson et al. 2011), in which phase I
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and II are conducted collaboratively. The methodology for the four phases is briefly
summarized below.
Phase I: Conceptualization and Literature Search
To ensure comparability between the CAT instrument and the original EORTC QLQ-
C30 questionnaire, the additional items for the insomnia item bank should reflect the
same underlying concept as the original item (i.e., “Have you had trouble sleeping?”).
Also, items should have the same response format and timeframe (i.e., a 4-point
polytomous response scale – “not at all,’ “a little,’ “quite a bit, “very much” during
the past week’), which allows assessment of the severity of insomnia.
WHO ICD-11 defines insomnia as a condition of impaired quantity and/or quality of
sleep resulting in daytime impairment (World Health Organization 2018). According to
Morin, the clinical significance of insomnia is determined by its intensity/severity,
frequency, duration, and daytime sequela (Morin 1993). Here we regard intensity/
severity, frequency and duration as reflecting the level of insomnia, while daytime
sequela is regarded as a potential consequence of insomnia. The original item asks
about insomnia in general and responses to the item may reflect any aspect of the level
of insomnia. To reflect the definition of insomnia and the general nature of the original
item, item selection and development focused on items indicating (1) any trouble with
sleeping (i.e. sleep quantity, such as trouble falling asleep or maintaining sleep) or (2)
the quality of sleep (e.g. restless sleep).
To identify self-report instruments and items assessing insomnia, we performed a
literature search in the e-resources PROQOLID, PubMed and the EORTC QLG Item
Library up to November 2007. Keywords used were ‘insomnia’, ‘sleepless’, ‘sleep-
lessness’, ‘wakefulness’ and ‘sleep’. The identified items served as a basis for the
generation of new items.
Phase II: Selection and Formulation of New Items
The item list resulting from phase I was refined following a multistep item selection
procedure. The first five steps were conducted by two members of the CAT project. The
first step comprised the classification of items into aspects of (1) ‘sleep quantity’, (2)
‘quality of sleep’ or (3) ‘other’. The next step focused on the deletion of duplicate
items, while in step 3 remaining items were used as inspiration to formulate new items
fitting the QLQ-C30 item style. In step 4 it was determined if the items covered all
aspects of insomnia. In case of insufficient coverage of the measurement continuum
(i.e. different levels of severity), new items could be generated in step 5. Lastly, items
were assessed by two groups of experts, QLG members and international experts on the
development of patient-reported outcome measures for cancer patients or on sleep
measurement, for their relevance to the construct insomnia, their appropriateness, and
for whether they were clear and well-defined.
Phase III: Pre-Testing
The preliminary item list resulting from phase II was pre-tested in an international
convenience sample of adult cancer patients (the specific countries were based on a
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convenience sample) to ensure content validity and appropriateness of the items. The
English item list was first translated into relevant languages by the Translation Unit of
the EORTC according to well-established guidelines, allowing that patients could
complete the questionnaire in their own language. (Kulis et al. 2016) Next, the item
list was administered to the patients. In addition, semi-structured interviews were
conducted with each patient to evaluate each item for wording (i.e., whether the items
were difficult, confusing, annoying, upsetting or intrusive) and whether relevant issues
were missing. If there were no comments or just a few comments on an item, these
were deemed relevant for phase IV where the psychometric analyses would provide
additional information on item relevance.
Phase IV: Field-Testing and Psychometric Analyses
Sample
We recruited a heterogeneous convenience sample of cancer patients across oncology
departments in Europe (Denmark, France, The Netherlands, Sweden and the United
Kingdom) and Taiwan. Eligible patients had to be over 18 years of age and have a
histologically verified cancer. Moreover, patients had to be able to understand and read
the questionnaire and informed consent form. To facilitate item calibration, we aimed to
include a minimum of 1000 patients with different cancer diagnoses, disease stages,
treatment modalities, and sociodemographic characteristics (Fayers 2007; Jiang et al.
2016; Muraki and Bock 1996).
Patients were requested to complete the questionnaire resulting from phase III, as
well as the EORTC QLQ-C30 and a short debriefing questionnaire to assess whether
patients found any of the items problematic. In addition, information on patient- and
disease-related characteristics was collected. The procedures performed in this study
are in accordance with the ethical standards of the institutional and/or national research
committee and with the 1964 Helsinki declaration and its later amendments, and the
ethical committees of all participating centres approved the study. Patients gave their
written informed consent before participation.
Descriptive and Basic Statistical Analyses
Descriptive statistics were used to characterize the patient sample, to calculate response
rates and item means with their standard deviations (SD), and investigate responses to
the debriefing questionnaires.
Evaluation of Dimensionality and Local Dependence
To evaluate if the requirements for unidimensionality and local dependence were met, both
exploratory and confirmatory factor analyses were performed (i.e. for ordinal categorical
data, with polychoric correlations, conducted in Mplus (Muthen and Muthen 2002)).
Eigenvalues and scree plot (Cattell 1966) were used to evaluate the dimensionality of the
items. The root mean square error of approximation (RMSEA) <0.10, the Comparative Fit
Index (CFI) >0.90, and the Tucker-Lewis Index (TLI) >0.90 (Browne and Cudek 1992;
Kline 2005) were used to define an acceptable model fit. Local independence (i.e., item
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responses are independent when controlling for the overall level of insomnia) was evaluated
by means of residual correlations, with correlations <0.20 serving as indicators for local
independence (Bjorner et al. 2003).
Item Bank Calibration and Evaluation of Item Fit
The generalized partial credit model (GPCM) (Muraki 1997) was used as basis for the
IRT modelling, with Parscale (Scientific Software International [SSI], Skokie, IL,
USA) for calibration of the model (Muraki and Bock 1996), as this model is a
generalization of other well-known IRT models, such as the Partial Credit Model which
can be further constrained to the Rating Scale Model. The GPCM model was also used
in the development of the item banks for the other domains of the QLQ-C30. Never-
theless, if one of the more restrictive models had a better fit with the data, that model
would have been applied for this specific item bank. Item fit was examined using the
item-fit test (Orlando and Thissen 2000), S-χ2, and bias and indices of fit were
evaluated by calculating the difference between expected and observed item
responses and the infit and outfit indices, respectively (Bond and Fox 2007). Infit
and outfit indices reflect the difference between expected responses of the model and
the actual observed responses to an item, and values between 0.7 and 1.3 were deemed
acceptable (Wright and Linacre 1994).
Test for Differential Item Functioning
To explore whether items function differently between subgroups of patients, we performed
differential item functioning (DIF) analysis. Using ordinal logistic regression methods
(performed in SAS version 9.3 (Sas I. I. 2004)), we tested for both uniform and non-
uniform DIF with regard to gender (male versus female), age (<40, 40–49, 50–59, 60–69,
≥70 years), country (Denmark, France, The Netherlands, Sweden, Taiwan, the United
Kingdom), cancer site (breast, gastrointestinal, genito-urinary, head & neck, lung, other
cancers) and stage (stage I-II versus stage III-IV), current treatment (chemotherapy, other
current treatment, no current treatment), cohabitation (living with a partner versus living
alone), work (working, retired or other), and educational level (0–10, 11–13, 14–16,
>16 years of education). Controlling for the insomnia score estimated in the previously
calibrated IRT model, each item was entered as outcome, and group (DIF) variables as
independent variables. DIF was considered relevant if p < 0.001 and if the regression
coefficient for the group variable was β > 0.64 (Bjorner et al. 1998; Petersen et al. 2003).
Next, the possible effect of DIF findings on the estimation of insomnia was evaluated (Hart
et al. 2009), by comparing scores obtained with a model accounting for DIF with the scores
obtained with the model from the previous step. DIF was only considered problematic if the
estimates of these two models differed more than the median standard error of the insomnia
estimates (Petersen et al. 2011, 2013b, 2016a; Hart et al. 2009).
Evaluation of Measurement Properties
The information function of the final item bank was calculated, and high measurement
precision was defined as an information score > 20, corresponding to a reliability of
>95% (Nunnally 1978).
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Simulations of CAT administration based on the collected data were performed to
further evaluate the measurement properties of the final CAT-SL. To evaluate possible
savings in sample size, the relative validity (RV, i.e. the ratio of two test statistics for
comparing two subgroups) of these CATs as compared to the QLQ-C30 insomnia scale
for detecting expected group differences was estimated using t-test statistics (Fayers
and Machin 2007). We expected that patients with good emotional functioning would
have less sleep problems than patients with poor functioning, and that patients with no/
limited pain would have less sleep problems than those with severe pain. Hence, these
groups were used to estimate the RVs. From the RVs we estimated the relative sample
size required using the CAT measures to obtain the same power as the QLQ-C30
insomnia scale (Petersen et al. 2013a). In addition to the evaluations based on the
observed data, we also evaluated the RV of the CATs based on simulated data across
different groups and group sizes (Petersen et al. 2013a).
Results
Phase I: Literature Search
A total of 69 items were retrieved from PROQOLID, one item from the EORTC QLG
Item Library, and 85 items were identified with the PubMed search, resulting in a total
of 155 items.
Phase II: Selection and Formulation of New Items
In the first step (classification of the items) 97 items were categorised as measuring
‘sleep quantity’, 24 items as measuring ‘sleep quality’ and 34 items as measuring
something other than sleep quantity/quality and hence irrelevant for the current purpose
(e.g. ‘How concerned are you about your sleeping?’). In the next step, duplicate items
and those that could not be reformulated into the QLQ-C30 item style were deleted,
which resulted in the removal of 104 of 121 items. Based on the 17 remaining items, 22
candidate items fitting the QLQ-C30 item style were formulated in step 3 (for 5/17
items two formulations were included, as it was unclear which one would be best,
resulting in 17 + 5 = 22 items). In step 4 it was determined if each item was most
relevant for patients with mild, moderate or severe insomnia (e.g. ‘Have you been
unable to sleep?’ seemed mostly relevant for patients with severe insomnia problems,
while ‘Have you had trouble staying asleep?’ seemed mostly relevant for patients with
moderate insomnia). Five items were rated as mostly relevant for patients with severe
insomnia, 16 items as mostly relevant for patients with moderate insomnia, and one
item as relevant for patients with mild insomnia. Although these results indicated that
more items for patients with mild insomnia are warranted, no new items were generated
in step 5, as the two reviewers were unable to come up with relevant items (and thought
this could possibly be added by external experts). Lastly (step 6), the items were
assessed by two groups of experts. Review by EORTC QLG members resulted in the
deletion of eight items, reformulation of three items, and the addition of three positively
formulated items. After these internal ratings, ten experts from Denmark, Canada,
The Netherlands, Sweden and the United Kingdom evaluated the remaining 17 items.
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Based on these evaluations, three items were deleted, two rephrased and one new item
was added, resulting in 15 candidate items of which two were positively formulated.
Phase III: Pre-Testing
The 15 items resulting from phase II were tested in a sample of 49 cancer patients from
Denmark, Italy, The Netherlands, Taiwan and the United Kingdom. The patients varied
in tumour type and stage, and treatment (see Table 1 for details on patients’ character-
istics). In general, the patients had few comments about the items. Based on the
patients’ comments, two items were deleted because of redundancy, and one item
was rephrased because the response format did not fit the question. No new items were
generated by patients. Hence, phase III resulted in an item list of 14 items, including the
original QLQ-C30 item (i.e. 13 items from phase III plus the original item, resulting in
14 items). See Table 2 for the complete item list.
Phase IV: Field-Testing and Psychometric Analyses
Sample
A large (n = 1094) heterogeneous sample of cancer patients was included in phase IVof
this study, with patients from Denmark, France, The Netherlands, Sweden, Taiwan and
United Kingdom (Table 1).
Descriptive and Basic Statistical Analyses
Response rates for the 14 items ranged between 97.4% and 98.8%, and item means
from 1.8–2.6 on a 1–4 scale (ranging from ‘not at all’ to ‘very much’). Each item was
rated as difficult, annoying or confusing by a maximum of 9 patients (0.8%). None of
the items was rated as upsetting or intrusive. Item 14 (‘felt rested’) correlated −0.58
with the QLQ-C30 item, and the remaining items correlated >± 0.72. Based on these
results, no items were deleted in this step.
Evaluation of Dimensionality and Local Dependence
Exploratory factor analysis showed that the first factor explained 75% of the total
variation (eigenvalue = 9.6). The second factor explained 6% of the variation but had an
eigenvalue <1. All other factors explained <5% of the variation. Evaluations indicated
that the two positively phrased items (#13 and #14) may form a separate factor. The
scree plot, however, indicated that one factor may suffice. To obtain a reasonable fit,
four items (items #2, #8, #13 and #14) had to be deleted. The remaining 10 items (items
1, 3–7, 9–12) constituted our candidate model and were evaluated using confirmatory
methods. The fit indices of this 10-item model were: RMSEA = 0.103, CFI = 0.988 and
TLI = 0.998, and one factor explained 80% of the variation. Although the RMSEAwas
just above 0.1, this set of items was deemed appropriate as a starting point for the IRT
analysis.
All of the 45 residual correlations were < 0.05, indicating that there was no local
dependence among the retained items.
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Table 1 Sociodemographic and clinical characteristics of the patients participating in phase III (pre-testing)
and phase IV (field-testing)
Characteristic Sample phase III (n = 49)
N (%) / mean
Sample phase IV (n = 1094)
N (%) / mean
Gender
Male 21 (42.9%) 541 (49.5%)
Female 28 (57.1%) 552 (50.5%)
Missing – 1 (0.1%)
Country
Denmark 10 (20.4%) 310 (28.3%)
France – 163 (14.9%)
Italy 15 (30.6%) –
The Netherlands 3 (6.1%) 28 (2.6%)
Sweden – 106 (9.7%)
United Kingdom 11 (22.4%) 383 (35%)
Taiwan 10 (20.4%) 104 (9.5%)
Missing – –
Age in years, mean 56 61
Cancer stage
I-II 18 (36.7%) 580 (53.0%)
III-IV 25 (51.0%) 485 (44.3%)
Unknown 6 (12.2%) 29 (2.7%)
Diagnosis
Breast 8 (16.3%) 224 (20.5%)
Gastrointestinal 10 (20.4%) 116 (10.6%)
Genito-urinary 5 (10.2%) 237 (21.7%)
Gynaecological 6 (12.2%) 151 (13.8%)
Head & Neck 5 (10.2%) 128 (11.7%)
Lung 3 (6.1%) 46 (4.2%)
Other 9 (18.4%) 190 (17.4%)
Missing 3 (6.1%) 2 (0.2%)
Current treatment
Chemotherapy 20 (40.8%) 277 (25.3%)
Other treatment 3 (6.1%) 281 (25.7%)
No treatment 24 (49.0%) 533 (48.7%)
Missing 2 (4.1%) 3 (0.3%)
Cohabitation
Live with partner 30 (61.2%) 803 (73.4%)
Live alone 16 (32.7%) 277 (25.3%)
Missing 3 (6.1%) 14 (1.3%)
Education*
0-10 years 8 (16.3%) 352 (32.2%)
11–13 years 13 (26.5%) 249 (22.8%)
14–16 years 14 (28.6%) 248 (22.7%)
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Item Bank Calibration and Evaluation of Item Fit
Inspecting the mean item scores in relation to the ‘rest score’ (i.e. sum score of all items
except the evaluated item) did not reveal problems with monotonicity, meaning that a
mean item score did not decrease when values of the ‘rest score’ were increasing.
Therefore, a GPCM (as this had a better fit than for example the GRM model (data not
shown)) was calibrated to the 10 remaining items. Items #6 and #12 had to be deleted to
obtain acceptable fit indices: bias estimates were all very close to zero, indicating no
Table 1 (continued)
Characteristic Sample phase III (n = 49)
N (%) / mean
Sample phase IV (n = 1094)
N (%) / mean
More than 16 years 13 (26.5%) 221 (20.2%)
Missing 1 (2.0%) 24 (2.2%)
Work
Fulltime 16 (32.7%) 272 (24.9%)
Part-time 5 (10.2%) 86 (7.9%)
Retired 15 (30.6%) 570 (52.1%)
Other 11 (22.4%) 159 (14.5%)
Missing 2 (4.1%) 7 (0.6%)
*All patients were literate, i.e. able to understand and read the questionnaires and informed consent form
Table 2 Parameter estimates and fit statistics for the 8 items in the final IRT model
Item Slope Location Item fit p
value
Bias Infit Outfit
Item 1: Has your sleep been restless? 2.33 0.69 0.20 −0.01 0.88 0.79
Item 2: Have you had trouble falling asleep? Excluded in phase IV
Item 3: Have you woken up during the night? 2.18 −0.03 0.42 0.00 0.85 0.82
Item 4: Have you woken up too early? 1.58 0.69 0.01 −0.01 0.92 0.86
Item 5: Have you had trouble staying asleep? 2.67 0.68 0.46 −0.02 0.85 0.73
Item 6: Have the nights been characterized by lack
of sleep?
Excluded in phase IV
Item 7: Have you had trouble sleeping? (QLQ-C30 item) 3.78 0.75 0.18 −0.02 0.74 0.56
Item 8: Have you had trouble returning to sleep if you
woke up during the night?
Excluded in phase IV
Item 9: Have you had trouble getting a good night’s sleep? 3.70 0.48 0.05 0.00 0.64 0.49
Item 10: Have you woken up for long periods during
the night?
2.53 0.83 0.18 −0.01 0.86 0.73
Item 11: Have you felt tired (not rested) when
you woke up?
1.44 0.59 0.39 −0.01 0.92 0.91
Item 12: Have you slept poorly? Excluded in phase IV
Item 13: Have you slept well? Excluded in phase IV
Item 14: Have you felt rested when you woke up? Excluded in phase IV
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systematic bias, and the RMSEAs were between 0.37 and 0.62, indicating some
variation in the precision of predicting item responses but not problematic (i.e. all
<1), and p values >0.01 (see Table 2 for details). The infits ranged from 0.64–0.92 and
the outfits from 0.49–0.91. Since values between 0.7 and 1.3 were deemed acceptable,
items #7 (original QLQ-C30 item) and #9 were problematic and probably reflect a
tendency for redundancy or local dependence. However, removing additional items
resulted in poor fit of one or more of the retained items. It was therefore decided to
continue with the 8-item pool in further analyses. The final 8-item model fulfilled all
criteria for acceptable fit: RMSEA = 0.080 and both CFI and TLI were > 0.99.
Test for Differential Item Functioning
Five items showed significant DIF, but only for age (one item) and country (four items)
(Table 3). Detailed evaluations showed that the effect of DIF had negligible impact on
insomnia estimation (data not shown). Therefore, all items were retained in the model.
Evaluation of Measurement Properties
Since re-addition of the discarded items to the model resulted in significantly poorer
model fit, the measurement properties of the item bank including eight items was
evaluated. Figure 1 shows the test information function for the eight items in the final
model, as well as for the original QLQ-C30 sleeplessness item. Insomnia scores ranged
from −1.84 (‘not at all’ on all items) to 2.59 (‘very much’ on all items). The total score
has very high measurement precision (reliability >0.95) for a small interval only (0.6–
Table 3 Results of the differential item functioning (DIF) analysis. For each group variable (e.g. country) one
Beta is presented summarizing the potential DIF, and the reference categories that were used in each case.
Conditional on the estimated insomnia scale score, a Beta coefficient > 0 indicates that the second group in the
bracket has a higher risk of reporting problems on the item. Beta <0 indicates that the first group has the
highest risk
Item DIF β P value
Item 1: Has your sleep been
restless?
Country 0.84 (Denmark and Sweden and France
versus United Kingdom and the
Netherlands and Taiwan)
<0.0001
Item 3: Have you woken up during
the night?
No DIF
Item 4: Have you woken up too early? Country −0.83 (France and The Netherlands
versus United Kingdom)
<0.0001
Item 5: Have you had trouble staying asleep? No DIF
Item 7: Have you had trouble sleeping? Country 1.12 (Taiwan versus United kingdom) <0.001
Item 9: Have you had trouble getting a
good night’s sleep?
Country 0.86 (Denmark and France versus all other
countries)
<0.0001
Item 10: Have you woken up for long
periods during the night?
No DIF
Item 11: Have you felt tired (not rested)
when you woke up?
Age −0.92 (age groups ≤50 versus age
groups >50 years)
<0.0001
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0.9), but has a reliability >0.90 in a much broader interval between −0.8 and 2.1 (three
standard deviation units). This means that the item bank is less precise for patients
without insomnia or those with severe insomnia. The item bank does result in markedly
higher measurement precision than the original item, with a reliability >0.5 across the
whole continuum.
Fig. 1 Test information function for the 8 items in the final model and the original QLQ-C30 sleeplessness
item. Scores for all response options (ranging from ‘not at all’ to ‘very much’) are presented. The θ of −1.84
reflects the score when ‘not at all’ is answered on all eight items, while the θ of 2.59 reflects the score when
‘very much’ is answered on all items. In addition, the level of measurement precision is presented on the y-
axis, with 90% reliability as the cut-off for good measurement precision
Fig. 2 Median and percentiles for differences between CAT versions with different lengths (θ estimate) and
the entire item bank (full-length θ)
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Figure 2 shows that for CATs of all lengths, the median insomnia score was very
similar to the score based on the entire item bank (median differences <0.02). Possible
savings in sample size were determined by known group comparisons based on both
the observed and simulated data. Observed and simulated data resulted in quite similar
findings (Fig. 3), with the observed data indicating slightly larger savings. On average,
across the two methods, the savings were between approximately 15–25% when using
two or more items.
Discussion
In this study we developed and evaluated an item bank for CAT measurement of
insomnia. The resulting EORTC CAT-SL item bank consists of eight items, including
the original item, and is applicable to a heterogeneous group of cancer patients across
countries.
Overall, the measurement precision of the item bank was higher than the original
QLQ-C30 SL item alone, across the whole continuum. Relatively high measurement
precision was observed for patients with moderate levels of insomnia. This is in line
with the finding that all items in the item bank were deemed particularly
relevant for patients with moderate insomnia. Importantly, the measurement
precision for patients without insomnia or with severe insomnia was subopti-
mal. In clinical practice this means that more detailed information would be
particularly useful for these patients. To further enhance measurement precision
of the item bank, new items primarily relevant for these latter patients could be
constructed and added. In contrast, for patients without insomnia this may be
irrelevant from a clinical perspective, because absence of insomnia is ‘normal’,
and interventions would not be necessary. For patients with severe insomnia
this could be relevant, as these patients would be eligible for further treatment.
Fig. 3 The relative required sample size in percentage using CAT measurement compared to using the QLQ-
C30 sleeplessness item for both observed data and simulated data. A smaller percentage indicates that smaller
sample sizes are required without reducing the power
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The final item bank consists of eight items and is therefore relatively small. In
comparison, the EORTC item banks for cognitive functioning and fatigue both consist
of 34 items (Dirven et al. 2017; Petersen et al. 2013a, 2018). However, only two items
are sufficient to improve the measurement precision and reduce sample sizes when
compared to single item assessment. Moreover, the items in the item bank not
only reflect the quantity of sleep, but also the quality of sleep. Therefore, the
whole construct of insomnia as we conceptualised it is covered in this item
bank. It should be noted though, that the literature search included articles up
to 2007 only as this was the first step in the developmental process, and
possible items assessing other concepts of insomnia may have been missed,
although we think that this is unlikely. Whether the level of insomnia as
measured with the CAT-SL is similar to the level of insomnia as measured
with other validated insomnia tools (whether or not specifically developed for
cancer patients) is not yet known. Future studies using these instruments in
parallel may clarify this. Of note, the eight items in the final item bank are all
negatively phrased. Although three positively phrased items were constructed
during the developmental process, the two items tested in phase IV loaded on a
different factor. Although mixing positively and negatively phrased items may
lessen the acquiescent response bias, it may also cause problems with reliability
and validity, questioning the use of both positively and negatively phrased
items in one questionnaire. (Roszkowski and Soven 2010) Lastly, in this study
we chose to comply with the standard EORTC response format to formulate our
items, although this is not required for IRT. In future studies it may be worth
exploring the impact of including items with different formats. Indeed, a
response format including the options ‘yes’ or ‘no’ would also fit the EORTC
items, as these are formulated in such a way that they can enquire about the
severity of an issue, but also presence versus absence.
The fit indices of the model with the eight items were not optimal, partly because of
the inclusion of the original item. However, since this item could not be deleted
(a policy of the EORTC Quality of Life Group), further evaluation of the item
bank was based on these eight items and showed that all could be retained in a
unidimensional item bank, with generally acceptable item fit. Even though quite
some items (5/8) showed DIF, this had negligible impact on the estimation of
insomnia (i.e. if the scores obtained with the model accounting for DIF were
similar to the model ignoring any possible DIF, the DIF for that item was
considered not to have practical importance). This means that insomnia scores
based on CAT-SL are not impacted by patient characteristics (i.e. gender, age,
country of residence, cancer site and stage, current treatment, cohabitation,
work and educational level), and can therefore be compared across studies.
As all EORTC questionnaires are developed cross-culturally, including many
languages, it may also be that DIF occurred due to linguistic reasons.
The estimated savings in sample size when using CAT varies between the domains
of the EORTC QLQ-C30, ranging from 15% for social functioning to 55% for
dyspnoea (Petersen et al. 2018). For the CAT-SL, savings in sample sizes between
approximately 15–25% can be achieved when administering two or more items with
CAT. Thus, fewer patients are needed to include in studies with insomnia as the primary
outcome. The response burden would be slightly higher for patients, as at least two
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items on insomnia need to be administered with CAT to all patients, compared to a
single item in the original QLQ-C30 questionnaire. On the other hand, considering that
HRQoL assessments comprises evaluation of multiple domains, the overall response
burden may be reduced for patients, as more concise assessment of many domains is
possible with the EORTC CAT measurement system.
The increased interest in CAT versions of patient-reported outcomes is based
on their potential for yielding more precise and efficient assessments as com-
pared to traditional instruments based on classical test theory. Enhanced mea-
surement efficiency and precision can be useful in both clinical studies and
clinical practice. In clinical studies, smaller sample sizes and reduced response
burden can contribute to higher compliance rates. Poor compliance with
HRQoL assessment is a major problem in cancer trials (Bernhard et al.
1998), especially during the follow-up period, hampering the interpretation of
results. In clinical practice, CAT can be used to monitor patients’ functioning
during the disease trajectory, or to facilitate patient-physician communication
(Detmar et al. 2002; Velikova et al. 2004, 2010). The burden of repeated
assessment of HRQoL in daily practice may be attenuated by CAT measure-
ment, by reducing the number of items that needs to be completed by patients
and by presenting different sets of items at each assessment point, thus
avoiding feelings of repetitiveness.
In conclusion, we have developed an eight item insomnia item bank for CAT
measurement relevant to various cancer patients in different countries. This new item
bank can be used in combination with the CAT versions of all of the other QLQ-C30
domains that have been developed or as ‘short-forms’ that can even be used in paper
and pencil questionnaires (http://qol.eortc.org/projectqol/eortc-cat/). The resulting CAT
instrument, the EORTC CAT Core, is now validated in an independent dataset.
(Petersen et al. 2018) With the EORTC CAT Core instrument, precise and efficient
assessment of HRQoL can be carried out, with clear utility in both clinical studies and
clinical practice.
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